Cargando…

Secondary Malignancy Risk Following Proton Radiation Therapy

Radiation-induced secondary malignancies are a significant, yet uncommon cause of morbidity and mortality among cancer survivors. Secondary malignancy risk is dependent upon multiple factors including patient age, the biological and genetic predisposition of the individual, the volume and location o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eaton, Bree R., MacDonald, Shannon M., Yock, Torunn I., Tarbell, Nancy J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2015
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4659915/ https://www.ncbi.nlm.nih.gov/pubmed/26636040 http://dx.doi.org/10.3389/fonc.2015.00261

Ejemplares similares

RONC-24. PROTON THERAPY FOR PEDIATRIC EPENDYMOMA: MATURE OUTCOMES FROM THE UNIVERSITY OF FLORIDA AND MASSACHUSETTS GENERAL HOSPITAL
por: Indelicato, Daniel J, et al.
Publicado: (2020)

Evaluation of permanent alopecia in pediatric medulloblastoma patients treated with proton radiation
por: Min, Chul Hee, et al.
Publicado: (2014)

Analysis of patient outcomes following proton radiation therapy for retinoblastoma
por: Mouw, Kent W., et al.
Publicado: (2016)

Proton vs. Photon Radiation Therapy for Primary Gliomas: An Analysis of the National Cancer Data Base
por: Jhaveri, Jaymin, et al.
Publicado: (2018)

GCT-37. PREVALENCE OF AUTISM SPECTRUM DISORDER AND OTHER NEURODEVELOPMENTAL DISORDERS IN PEDIATRIC PATIENTS WITH INTRACRANIAL GERM CELL TUMORS
por: Liu, Kevin X, et al.
Publicado: (2020)

Risk of secondary malignant neoplasms in children following proton therapy vs. photon therapy for primary CNS tumors: A systematic review and meta-analysis
por: Upadhyay, Rituraj, et al.
Publicado: (2022)

Predicted Secondary Malignancies following Proton versus Photon Radiation for Oropharyngeal Cancers
por: Jain, Varsha, et al.
Publicado: (2020)

Proton Radiotherapy for Pediatric Sarcoma
por: Ladra, Matthew M., et al.
Publicado: (2014)

Patient Prioritization for Proton Beam Therapy in a Cost-neutral Payer Environment: Use of the Clinical Benefit Score for Resource Allocation
por: Sharma, Ankur M, et al.
Publicado: (2019)

Radiation Necrosis with Proton Therapy in a Patient with Aarskog-Scott Syndrome and Medulloblastoma
por: Puthenpura, Vidya, et al.
Publicado: (2021)

Secondary Malignancy Risk Following Proton vs. X-ray Treatment of Mediastinal Malignant Lymphoma: A Comparative Modeling Study of Thoracic Organ-Specific Cancer Risk
por: König, Laila, et al.
Publicado: (2020)

Risk and prognosis of secondary malignant neoplasms after radiation therapy for bladder cancer: A large population-based cohort study
por: Chen, Ru, et al.
Publicado: (2022)

Proton Radiotherapy for Solid Tumors of Childhood
por: Cotter, Shane E., et al.
Publicado: (2012)

Risk of secondary malignancy following radiation therapy for prostate cancer
por: Tiruye, Tenaw, et al.
Publicado: (2023)

Immunotherapy Combined With Radiation Therapy for Genitourinary Malignancies
por: Ukleja, Jacob, et al.
Publicado: (2021)

Lifetime attributable risk of radiation-induced secondary cancer from proton beam therapy compared with that of intensity-modulated X-ray therapy in randomly sampled pediatric cancer patients
por: Tamura, Masaya, et al.
Publicado: (2017)

Proton pump inhibitors and sensitization of cancer cells to radiation therapy
por: Hebert, Kassidy A., et al.
Publicado: (2022)

Proton versus photon radiation therapy: A clinical review
por: Chen, Zhe, et al.
Publicado: (2023)

Intensity modulated radiation therapy versus three‐dimensional conformal radiation therapy for the treatment of high grade glioma: a dosimetric comparison
por: MacDonald, Shannon M., et al.
Publicado: (2007)

Proton Therapy for Malignant Pleural Mesothelioma: A Three Case Series Describing the Clinical and Dosimetric Advantages of Proton-Based Therapy
por: Lee, Howard, et al.
Publicado: (2017)

Risk and Prognosis of Secondary Rectal Cancer After Radiation Therapy for Pelvic Cancer
por: Yang, Runkun, et al.
Publicado: (2020)

Risk and prognosis of secondary bladder cancer after radiation therapy for pelvic cancer
por: Li, Shuofeng, et al.
Publicado: (2022)

An Update From the Pediatric Proton Consortium Registry
por: Hess, Clayton B., et al.
Publicado: (2018)

Radiation Induced Cavernomas in the Treatment of Pediatric Medulloblastoma: Comparative Study Between Proton and Photon Radiation Therapy
por: Trybula, S. Joy, et al.
Publicado: (2021)

The Pediatric Proton and Photon Therapy Comparison Cohort: Study Design for a Multicenter Retrospective Cohort to Investigate Subsequent Cancers After Pediatric Radiation Therapy
por: Berrington de González, Amy, et al.
Publicado: (2023)

Comparative Cost-Effectiveness of Stereotactic Body Radiation Therapy Versus Intensity-Modulated and Proton Radiation Therapy for Localized Prostate Cancer
por: Parthan, Anju, et al.
Publicado: (2012)

External Beam Radiation Therapy in Treatment of Malignant Pheochromocytoma and Paraganglioma
por: Vogel, Jennifer, et al.
Publicado: (2014)

The Role of Hypofractionated Radiation Therapy with Photons, Protons, and Heavy Ions for Treating Extracranial Lesions
por: Laine, Aaron Michael, et al.
Publicado: (2016)

Long-term follow up of patients with hematological malignancies treated with total body irradiation using intensity modulated radiation therapy
por: Ladbury, Colton, et al.
Publicado: (2022)

Onboard cone‐beam CT‐based replan evaluation for head and neck proton therapy
por: Stanforth, Alexander, et al.
Publicado: (2022)

Combining Radiation Therapy with Immune Checkpoint Blockade for Central Nervous System Malignancies
por: D’Souza, Neil M., et al.
Publicado: (2016)

Selecting the Appropriate Radiation Therapy Technique for Malignant Spinal Cord Compression Syndrome
por: Lee, Jun-Ho, et al.
Publicado: (2019)

Cancer Control, Toxicity, and Secondary Malignancy Risks of Proton Radiation Therapy for Stage I-IIB Testicular Seminoma
por: Maxwell, Russell, et al.
Publicado: (2023)

The current role of secondary cytoreductive surgery for recurrent ovarian cancer
por: de Bree, Eelco, et al.
Publicado: (2022)

NTCP Models for Severe Radiation Induced Dermatitis After IMRT or Proton Therapy for Thoracic Cancer Patients
por: Palma, Giuseppe, et al.
Publicado: (2020)

Reconstructive complications and early toxicity in breast cancer patients treated with proton-based postmastectomy radiation therapy
por: Sayan, Mutlay, et al.
Publicado: (2023)

[(18)F]FET-PET Imaging for Treatment and Response Monitoring of Radiation Therapy in Malignant Glioma Patients – A Review
por: Götz, I., et al.
Publicado: (2013)

Dysuria Following Stereotactic Body Radiation Therapy for Prostate Cancer
por: Janowski, Einsley-Marie, et al.
Publicado: (2015)

Early biochemical outcomes following neoadjuvant/adjuvant relugolix with stereotactic body radiation therapy for intermediate to high risk prostate cancer
por: Gallagher, Lindsey, et al.
Publicado: (2023)

Radiation Therapy for Malignant Lumbosacral Plexopathy: A Case Series
por: Sanuki, Naoko, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rm7eooq7bu1s4ku1pmnd58034j